Holders over time
- CI
- ELV
| Quarter | CI | ELV |
|---|---|---|
| Q3 2020 | 34 holders, $18.1bn | 30 holders, $15.0bn |
| Q4 2020 | 22 holders, $21.9bn | 29 holders, $16.7bn |
| Q1 2021 | 24 holders, $23.9bn | 25 holders, $18.6bn |
| Q2 2021 | 31 holders, $22.5bn | 30 holders, $19.4bn |
| Q3 2021 | 30 holders, $17.8bn | 26 holders, $18.5bn |
| Q4 2021 | 26 holders, $20.1bn | 29 holders, $23.3bn |
| Q1 2022 | 28 holders, $20.4bn | 31 holders, $23.9bn |
| Q2 2022 | 32 holders, $22.1bn | 32 holders, $23.3bn |
| Q3 2022 | 31 holders, $21.5bn | 34 holders, $22.6bn |
| Q4 2022 | 30 holders, $24.7bn | 34 holders, $25.5bn |
| Q1 2023 | 35 holders, $18.2bn | 39 holders, $22.5bn |
| Q2 2023 | 30 holders, $19.8bn | 38 holders, $20.6bn |
| Q3 2023 | 28 holders, $19.8bn | 34 holders, $19.8bn |
| Q4 2023 | 31 holders, $20.6bn | 36 holders, $20.3bn |
| Q1 2024 | 28 holders, $24.0bn | 35 holders, $21.3bn |
| Q2 2024 | 28 holders, $19.5bn | 33 holders, $22.1bn |
| Q3 2024 | 25 holders, $20.2bn | 30 holders, $20.2bn |
| Q4 2024 | 23 holders, $15.2bn | 32 holders, $15.9bn |
| Q1 2025 | 24 holders, $18.4bn | 28 holders, $17.1bn |
| Q2 2025 | 34 holders, $19.5bn | 27 holders, $14.8bn |
| Q3 2025 | 28 holders, $16.2bn | 27 holders, $12.7bn |
| Q4 2025 | 21 holders, $14.6bn | 25 holders, $17.0bn |
| Q1 2026 | 26 holders, $13.5bn | 26 holders, $13.6bn |
| Q2 2026 | 28 holders, $13.0bn | 28 holders, $17.7bn |
The Cigna Group
- Holders
- 26
- Reported value
- $13.5bn
- Buyers
- 19
- Sellers
- 20
Breadth -1 among 91 comparable managers.
Elevance Health Inc Formerly
- Holders
- 26
- Reported value
- $13.6bn
- Buyers
- 24
- Sellers
- 17
Breadth +7 among 91 comparable managers.
Who holds both, Q1 2026
Both (10)
Acadian Asset Management LLC, AllianceBernstein LP, Arrowstreet Capital LP, Capital Research Global Investors, Dodge & Cox, Fidelity (FMR LLC), Invesco Ltd, MFS Investment Management, Schonfeld Strategic Advisors LLC, T. Rowe Price Associates Inc
Only CI (16)
AQR Capital Management LLC, Bridgewater Associates LP, Capital World Investors, Caxton Associates LLP, ExodusPoint Capital Management LP, GAMCO Investors Inc, Glenview Capital Management LLC, Greenlight Capital, Man Group PLC, Moore Capital Management LP, Neuberger Berman Group LLC, Quantbot Technologies LP, Renaissance Technologies LLC, Two Sigma Investments LP, Verition Fund Management LLC, Walleye Capital LLC
Only ELV (16)
Artisan Partners LP, Baillie Gifford & Co, Balyasny Asset Management LLC, Baupost Group LLC, Brevan Howard Capital Management LP, Citadel Advisors LLC, D. E. Shaw & Co., Davidson Kempner Capital Management LP, First Eagle Investment Management LLC, Freestone Grove Partners LP, Harris Associates LP, Holocene Advisors LP, Janus Henderson Group Ltd, Millennium Management LLC, Ruane Cunniff & Goldfarb LP, Wellington Management Group LLP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.